Pfizer&#39;s bid to save Celebrex may get boost from data
496302
Pfizer Inc.&#39;s bid to head off a Celebrex recall may get a boost from new government data showing the painkiller didn&#39;t raise heart risks in a study, while Aleve, which is sold by Bayer AG, did, investors said.
665220
Scientists in the United States and Great Britain are calling for a fresh look at Celebrex and other medications similar to Vioxx, the heavily advertised arthritis drug pulled from the market last week after a study suggested it doubled the risk of heart attacks and strokes.
422800
NEW YORK, December 30  - New prescriptions for pharmaceutical major Pfizerâs (PFE.NYS) arthritis drug Celebrex declined 56% last week after the company revealed that the regular usage of the drug could enhance the risk of heart attacks
227257
Pfizer Inc. said Friday that it found an increased risk of heart attacks and strokes for patients taking high dosages of its top-selling arthritis painkiller Celebrex, the same
722145
Will Pfizer be able to offset the looming loss of Lipitor?
424951
NEW YORK - A new round of trials have shown a boosted risk of heart problems among patients taking the painkiller Celebrex, manufacturer Pfizer Inc.
758212
As Pfizer&#39;s (PFE:NYSE - news - research) Celebrex safety hiccup was unfolding Friday, I had a running conversation with a fund manager.
493704
Pfizer is pulling its radio, TV, newspaper and magazine advertising for Celebrex in the wake of a study that links high doses of the popular arthritis to an increased risk of heart attack, but the company plans to keep Celebrex on the market.
675856
Pharmaceutical giant Pfizer Inc. has acknowledged that a 1999 study found Alzheimer's patients taking the pain killer Celebrex were up to four times more likely to have cardiovascular risk factors than those taking a placebo.
119087
Pfizer Inc. says it will immediately pull advertising for its top-selling arthritis pain reliever Celebrex, whose safety was called into question last week after a study found an increased risk of heart attacks in patients taking high dosages of the drug.
20994
Pfizer plans to ask or approval of torcetrapib, a heart drug crucial to the companyÂs future, despite evidence that the drug increases blood pressure.
355446
Pfizer said today that it would sponsor a major clinical trial of Celebrex, its prescription arthritis pain medication, to assess the cardiovascular benefits of the drug.
45984
Drug company Pfizer said today it is continuing to promote its arthritis drug Celebrex to doctors despite reports it more than doubles the risk of heart attacks and strokes.
41856
Pfizer Inc.âs disclosure of a study linking Celebrex to heart attacks, such as Merck &amp; Co.âs withdrawn Vioxx, means demand for the drugs once known as âsuper aspirin
149032
The stock is feeling some pain these days. However, this drugmaker has enough going for it that the illness shouldn&#39;t last. Amid nervousness over the future of Pfizer&#39;s arthritis pain treatment Celebrex and
497581
U.S. drug reviewers have questioned Pfizer Inc.'s  data showing the pain reliever Celebrex was as effective as an older drug in treating juvenile rheumatoid arthritis, according to documents released on Tuesday.
31944
Pharmaceutical giant Pfizer Inc. will  announce plans for a large-scale clinical trial of the ability  of blockbuster drug Celebrex to prevent heart attacks and  strokes in patients with cardiovascular disease, the Wall  Street Journal reported on Monday.